Literature DB >> 2479563

A heat shock-like protein from the human malaria parasite Plasmodium falciparum induces autoantibodies.

D Mattei1, A Scherf, O Bensaude, L P da Silva.   

Abstract

The humoral immune response to a 72-kDa heat shock-like protein of Plasmodium falciparum has been analyzed using mouse monoclonal antibodies (mAb) and human immune sera. Three regions of the molecule containing B cell epitopes were identified by screening a sublibrary encoding the COOH-terminal half of the antigen with the mAb. One B cell epitope mapped to a region poorly conserved between the parasite 72-kDa polypeptide and mammalian heat-shock proteins (Hsp 70). Another mAb, G10C9, reacted with an amino acid region that has a high degree of homology with mouse (87.5%) and human (81.2%) Hsp 70. Both mouse and human cells were recognized by this mAb when analyzed by indirect immunofluorescence and by two-dimensional immunoblots. Sera from humans infected with malaria also recognized the human Hsp 70. Thus, our results indicate that autoantibodies directed against host Hsp 70 can be induced by the homologous parasite protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479563     DOI: 10.1002/eji.1830191010

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  The transport of proteins into the nucleus requires the 70-kilodalton heat shock protein or its cytosolic cognate.

Authors:  Y Shi; J O Thomas
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

Review 2.  Parasite heat-shock proteins and host responses: the balance between protection and immunopathology.

Authors:  D Mazier; D Mattei
Journal:  Springer Semin Immunopathol       Date:  1991

3.  Antibodies to a conserved-motif peptide sequence of the Plasmodium falciparum thrombospondin-related anonymous protein and circumsporozoite protein recognize a 78-kilodalton protein in the asexual blood stages of the parasite and inhibit merozoite invasion in vitro.

Authors:  P Sharma; A Bharadwaj; V K Bhasin; V N Sailaja; V S Chauhan
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Antibodies to a non-repeat region of Plasmodium falciparum antigen Pf155/RESA in individuals from malaria-endemic areas.

Authors:  A B Siddique; N Ahlborg; M Warsame; P Perlmann; K Berzins
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

5.  Disease association of antibodies to human and mycobacterial hsp70 and hsp60 stress proteins.

Authors:  A Elsaghier; C Prantera; G Bothamley; E Wilkins; S Jindal; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

6.  The ABA-1 allergen of the nematode Ascaris suum: epitope stability, mass spectrometry, and N-terminal sequence comparison with its homologue in Toxocara canis.

Authors:  J F Christie; B Dunbar; M W Kennedy
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

7.  The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses.

Authors:  M P Davenport; K R McKenzie; A Basten; W J Britton
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites.

Authors:  M Tsuji; D Mattei; R S Nussenzweig; D Eichinger; F Zavala
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

9.  Mapping of a visceral leishmaniasis-specific immunodominant B-cell epitope of Leishmania donovani Hsp70.

Authors:  G R Wallace; A E Ball; J MacFarlane; S H el Safi; M A Miles; J M Kelly
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

10.  Induction of opsonizing antibodies after injection of recombinant Plasmodium falciparum vaccine candidate antigens in preimmune Saimiri sciureus monkeys.

Authors:  R Perraut; O Mercereau-Puijalon; D Mattei; E Bourreau; O Garraud; B Bonnemains; L Pereia de Silva; J C Michel
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.